In addition, we identified a novel mechanism through which CML promotes glucose metabolism in VSMCs in a PDK4-dependent manner; in contrast, CML-induced glucose metabolism is hampered by PDK4 siRNA silencing or DCA treatment. Here, PDK4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.